{"gene":"CD2","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1987,"finding":"LFA-3 (CD58) was identified as the physiological cell-surface ligand for CD2; LFA-3 cDNA encodes a phospholipid-linked (GPI-anchored) membrane protein whose extracellular domain shares homology with CD2, and CD2-LFA-3 interaction mediates T cell adhesion and conjugate formation.","method":"cDNA cloning, transient expression system, functional adhesion assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — original ligand identification by cDNA cloning and expression, foundational paper with >700 citations","pmids":["3313052"],"is_preprint":false},{"year":1987,"finding":"Binding of LFA-3 (T11 target structure) to CD2 on T cells provides one of the signals required for alternative pathway T cell activation, rendering resting T cells responsive to mitogenic anti-CD2 stimuli.","method":"Functional T cell activation assays with natural ligand and anti-CD2 mAbs","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — direct ligand-receptor functional assay, >275 citations","pmids":["3102975"],"is_preprint":false},{"year":1989,"finding":"The extracellular domain of CD2 is organized in two Ig-like domains; the NH2-terminal domain (exon 2, ~103 aa) is sufficient for LFA-3 binding with a Kd of ~0.4 µM, is resistant to proteolysis despite lacking intrachain disulfides, and ligand binding is not regulated by the cytoplasmic domain.","method":"Baculovirus and eukaryotic expression of recombinant CD2 fragments, circular dichroism, binding assays, truncation mutagenesis","journal":"Immunological reviews / The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — recombinant protein binding assay with mutagenesis, replicated in multiple papers","pmids":["2576417","2466941"],"is_preprint":false},{"year":1988,"finding":"CD2 activation pathway is interdependent with CD3-Ti: Jurkat mutants lacking surface CD3-Ti fail to be activated through CD2 (no phosphoinositide turnover, Ca2+ mobilization, or IL-2 induction), and CD3-Ti re-expression restores CD2-mediated signaling.","method":"Jurkat mutant cell lines, DNA transfection reconstitution, phosphoinositide turnover, Ca2+ mobilization assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genetic reconstitution epistasis in defined mutant cell lines, replicated","pmids":["2901344"],"is_preprint":false},{"year":1990,"finding":"CD2 is physically associated with CD45 (T200, leukocyte common antigen) on the surface of human and mouse T lymphocytes, as demonstrated by chemical cross-linking and co-immunoprecipitation; CD45 tyrosine phosphatase activity may explain CD45's co-mitogenic effect with anti-CD2 antibodies.","method":"Chemical crosslinking, co-immunoprecipitation, co-precipitation from detergent lysates","journal":"Nature / International immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-precipitation and crosslinking, replicated in two independent labs (human and mouse)","pmids":["1970422","1980615"],"is_preprint":false},{"year":1991,"finding":"CD2 adhesion function is constitutively active in resting T cells and is not upregulated by TCR stimulation, in contrast to LFA-1 whose adhesion is minimal at rest and rapidly augmented by TCR-mediated activation; this complementarity positions CD2 to initiate cell-cell contact before TCR engagement.","method":"Cell adhesion assays, PKC activation, cAMP manipulation, surface redistribution analysis","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple pharmacological perturbations across activation states, >80 citations","pmids":["1672642"],"is_preprint":false},{"year":1991,"finding":"Lateral mobility of LFA-3 and CD2 on membranes enhances adhesion strengthening; GPI-anchored LFA-3 (mobile) supports faster adhesion strengthening than transmembrane LFA-3 (immobile), and reducing CD2 mobility decreases adhesion strengthening rate.","method":"Reconstituted planar lipid bilayers, static and laminar flow adhesion assays, fluorescence recovery after photobleaching","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted bilayer system with quantitative adhesion measurement, >170 citations","pmids":["1717480"],"is_preprint":false},{"year":1992,"finding":"The CD3 zeta cytoplasmic domain is necessary and sufficient to couple CD2 to intracellular signal transduction (Ca2+ mobilization, protein tyrosine kinase activation, IL-2 secretion) in Jurkat cells lacking CD3-Ti, established by a CD8α/CD3ζ chimeric receptor transfection.","method":"Chimeric cDNA transfection into CD3-deficient Jurkat variants, Ca2+ measurement, PTK assay, IL-2 ELISA","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with defined chimeric protein, specific gain-of-function","pmids":["1351920"],"is_preprint":false},{"year":1992,"finding":"TCR-CD3 crosslinking rapidly increases CD2 avidity for CD58 (LFA-3); mutational analysis of the CD2 cytoplasmic domain shows the carboxyl-terminal asparagine is essential for avidity regulation but not for CD2-mediated signaling, defining structurally distinct functional domains; loss of avidity regulation impairs antigen-specific T cell responses.","method":"Mutational analysis of CD2 cytoplasmic domain, CD58 binding assays, antigen-specific T cell activation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — site-directed mutagenesis with functional readout, defines discrete domains","pmids":["1353888"],"is_preprint":false},{"year":1992,"finding":"N-glycosylation at Asn65 in domain 1 of CD2 is required for LFA-3 (CD58) binding and for recognition by adhesion-domain-specific anti-CD2 mAbs; high mannose oligosaccharides occupy Asn65; deglycosylation or Asn65Gln mutation abolishes CD2 adhesion function by destabilizing domain 1.","method":"Site-directed mutagenesis (Asn65Gln), enzymatic deglycosylation, binding assays, electrospray ionization-mass spectrometry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with structural characterization and functional binding assay","pmids":["1385399"],"is_preprint":false},{"year":1993,"finding":"CD2 binds CD48 via its NH2-terminal Ig domain in rats (and by analogy mice) with low affinity (Kd upper limit ~2.5 µM); binding does not require glycosylation of CD2 and is direct as shown by solution binding of bacterially expressed domain 1.","method":"Soluble chimeric CD48-CD4 protein, rosetting assay, sucrose gradient ultracentrifugation, bacterial expression of CD2 domain 1","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — direct solution binding assay with recombinant minimal domain","pmids":["8099016"],"is_preprint":false},{"year":1994,"finding":"CD2 forms a signaling complex with CD3 zeta chain and the Src-family tyrosine kinases p59fyn and p56lck in T lymphocytes, as identified by co-immunoprecipitation and in vitro kinase assays on CD2 immunoprecipitates; double immunofluorescence confirms the complex in living T cells.","method":"Co-immunoprecipitation, in vitro kinase assay, double indirect immunofluorescence with capping","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — co-IP with kinase activity assay and orthogonal imaging confirmation","pmids":["7912674"],"is_preprint":false},{"year":1998,"finding":"An intracellular adaptor protein CD2BP2 binds two PPPGHR proline-rich segments in the CD2 cytoplasmic tail via a novel 17-aa GYF motif; overexpression of the CD2BP2 binding domain in Jurkat cells enhances IL-2 production upon CD2 crosslinking but not TCR crosslinking.","method":"Yeast two-hybrid, NMR analysis, mutagenesis, Jurkat overexpression with IL-2 reporter","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — NMR structure + mutagenesis + functional cellular assay in single study","pmids":["9843987"],"is_preprint":false},{"year":1998,"finding":"CD2 can signal through a p56lck-independent pathway involving Jun kinase activation; CD2-mediated IL-2 production occurs via JNK-dependent AP-1 activation in T cell lines lacking p56lck, whereas TCR-triggered activation requires p56lck.","method":"p56lck-deficient Jurkat cell lines, JNK kinase assays, AP-1/IL-2 promoter reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — defined genetic loss-of-function cell lines with biochemical pathway dissection","pmids":["9727049"],"is_preprint":false},{"year":1999,"finding":"CD2 sets quantitative activation thresholds; CD2-deficient T cells show a 3–10-fold rightward shift in antigen dose-response in vitro, impaired TCR triggering and Ca2+ flux at low antigen density; CD2 and LFA-1 adhesion pathways function additively.","method":"CD2 knockout mice crossed with TCR-transgenic mice, dose-response proliferation assays, conjugate formation, TCR triggering, Ca2+ flux measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple orthogonal readouts and quantitative dose-response","pmids":["10562314"],"is_preprint":false},{"year":2000,"finding":"p59fyn is a critical Src-family PTK upstream in the CD2 signaling pathway; in fyn-/- mice expressing transgenic human CD2, CD2-triggered Ca2+ mobilization, MAPK activation and proliferation are markedly reduced, while TCR-triggered proliferation is unaffected; CD2 substrates regulated by fyn include PLC-γ1, Vav, PKC-θ, Dok, FAK and Pyk2.","method":"Transgenic human CD2 in fyn-/- mice, Ca2+ mobilization, MAPK assays, substrate phosphorylation analysis","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — defined genetic KO with multiple biochemical substrates characterized","pmids":["11093170"],"is_preprint":false},{"year":2001,"finding":"CD2 is inducibly recruited into lipid raft microdomains upon crosslinking by anti-CD2 mAbs or CD58 engagement; raft integrity is required for CD2-stimulated Ca2+ elevation and tyrosine phosphorylation; translocation requires ectodomain conformational change and is independent of TCR and cytoplasmic tyrosine phosphorylation; murine CD2 partitions constitutively into rafts via membrane-proximal cytoplasmic cysteines absent in human CD2.","method":"Lipid raft fractionation, cholesterol depletion, CD2 point mutation/deletion/chimeric constructs, Ca2+ and phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — fractionation with multiple mutants and functional consequences characterized","pmids":["11376005"],"is_preprint":false},{"year":2001,"finding":"p62dok negatively regulates CD2 signaling in Jurkat T cells; overexpression of p62dok inhibits CD2-induced Ca2+ increase, PLC-γ1 activation, and ERK1/2 activation but not CD3/TCR-induced equivalents; CD2 (but not CD3) stimulation induces p62dok and RasGAP recruitment to the plasma membrane.","method":"Jurkat overexpression clones, Ca2+ flux, PLC-γ1 and ERK assays, subcellular fractionation","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — defined overexpression with multiple specific biochemical readouts pathway-specifically attributed to CD2","pmids":["11254695"],"is_preprint":false},{"year":2002,"finding":"CD2 engagement with CD58 induces T cell polarization and scanning motility along APC surfaces; CD2 molecules rapidly redistribute to the uropod with ~100-fold greater density versus the leading edge; CD2, TCR, and lipid rafts co-compartmentalize in the uropod, forming a 'presynapse'; scanning requires β-integrin function and myosin light chain kinase.","method":"Time-lapse DIC and immunofluorescence microscopy on living T cells, pharmacological inhibition","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — live-cell imaging with quantitative redistribution data and pharmacological validation","pmids":["12032326"],"is_preprint":false},{"year":2007,"finding":"CD2-CD58 interaction at the immunological synapse augments and sustains antigen-induced Ca2+ increase in individual T cells and is required for PLCγ1 recruitment to the IS and phosphorylation of PLCγ1 at Tyr783; TCR and CD2 signals converge on PLCγ1 activation.","method":"Single-cell Ca2+ imaging, IS immunofluorescence, PLCγ1 phosphorylation assays, anti-CD58 blocking","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 2 — single cell imaging plus defined biochemical pathway with blocking experiments","pmids":["17220479"],"is_preprint":false},{"year":2008,"finding":"Nanoscale increases in CD2-CD48 intermembrane spacing (by 2–4 nm achieved using elongated CD48 chimeras) reduce adhesion efficiency 10-fold and reorganize the immunological synapse; increased spacing causes eccentric CD2/TCR cluster formation and dramatically reduces T cell sensitivity.","method":"Electron tomography, confocal imaging, primary T cell activation assays, CD48 Ig-domain extension chimeras","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structural measurement by EM tomography with functional consequence in primary cells","pmids":["18826951"],"is_preprint":false},{"year":2009,"finding":"CD58 ligation of CD2 alone (without TCR activation) induces actin-dependent coalescence of signaling molecules (TCR-ζ, Lck, LAT) into plasma membrane microdomains in Jurkat cells on planar bilayers; CD2 and TCR initially colocalize in microdomains then partition into separate zones enabling synergistic signaling.","method":"Planar lipid bilayer model system, single-molecule fluorescence imaging, Jurkat T cells","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reconstituted model system with single-molecule resolution imaging","pmids":["19398758"],"is_preprint":false},{"year":2009,"finding":"CD2 and GPI-anchored CD48 cooperate hierarchically in building the early TCR signalosome; CD2 associates with TCR/CD3 upon T cell activation irrespective of CD48 expression and recruits Lck; CD48 then shuttles the transmembrane adaptor LAT to the TCR/CD3 complex in a CD2-dependent manner.","method":"Co-immunoprecipitation, CD48 knockdown/knockout, LAT and Lck recruitment assays, IL-2 production","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — epistasis by sequential co-IP and genetic KD defining hierarchy","pmids":["19494291"],"is_preprint":false},{"year":2020,"finding":"CD2 localizes to the outer edge of the mature immunological synapse (the 'CD2 corolla') where it captures engaged CD28, ICOS, CD226 and SLAM-F1 co-stimulators; CD2-CD58 interactions in the corolla amplify phosphorylated SFK, LAT and PLC-γ signaling by ~77% versus central CD2-CD58; engaged PD-1 invades the CD2 corolla and buffers CD2-mediated TCR signal amplification; CD2 cytoplasmic tail motifs and copy number control corolla formation.","method":"Super-resolution/confocal imaging with cellular and artificial APC, genetic CD2 mutants, phospho-signaling measurements, primary T cell experiments","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal imaging and biochemical methods with defined mutants, >100 citations","pmids":["32929275"],"is_preprint":false},{"year":2022,"finding":"CD2 on T cells forms cis interactions with its ligand CD48 within the same T cell membrane (demonstrated by FRET); these T cell-intrinsic cis CD2-CD48 interactions are required for robust TCR signaling (protein tyrosine phosphorylation); CD48 is needed on T cells but not APCs for T cell activation (except during cytotoxicity where CD48 on APCs is also required); mass spectrometry of knock-in-tagged CD2 reveals association with TCR complex components and Lck.","method":"FRET in nonimmune cells, CD2/CD48 knockout mouse strains, mass spectrometry of CD2-KI tag IP, PTK phosphorylation assays, cytotoxicity assays","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1–2 — FRET structural evidence + KO epistasis + MS interactome in single study","pmids":["35930657"],"is_preprint":false},{"year":1992,"finding":"CD59 (a GPI-anchored complement regulatory protein) functions as a second ligand for CD2 on T cells; CD2+ transfectants form rosettes with CD59-expressing CHO cells, blocked by anti-CD59 and anti-CD2 mAbs; 125I-CD59 binds specifically to CD2+ CHO cells; CD59 binding induces CD2R epitope expression.","method":"Rosette assays with transfected CHO cells, 125I-labeled CD59 binding, antibody blocking","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assay with radiolabeled ligand, single lab","pmids":["1385156"],"is_preprint":false},{"year":1999,"finding":"CD2 and CD3 independently associate with CD5 in T lymphocytes; CD5 is tyrosine phosphorylated after CD3 stimulation but dephosphorylated after CD2 crosslinking; this difference correlates with decreased SHP-1 activity in CD3 pathway versus enhanced SHP-1 after CD2 triggering, defining a regulatory link between CD2 and the phosphatase SHP-1 via CD5.","method":"Co-immunoprecipitation in CD3- and CD2-deficient cells, CD5 phosphorylation assays, SHP-1 activity assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP in defined mutant cells with phosphatase activity assay, single lab","pmids":["10510361"],"is_preprint":false},{"year":2000,"finding":"Double knockout of CD2 and CD28 in mice causes profound defect in T cell activation by soluble anti-CD3 and antigen but not by immobilized anti-CD3, indicating CD2 and CD28 function coordinately to facilitate T cell-APC interactions for efficient TCR signaling.","method":"Double KO mice, T cell activation assays with soluble vs. immobilized stimuli","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — clean double-KO epistasis with defined phenotypic readout","pmids":["10725714"],"is_preprint":false},{"year":2006,"finding":"CD2 promotes membrane nanotube formation between NK cells and susceptible target cells; CD2-CD58/48 receptor-ligand interaction is required for nanotube formation; CD2 localizes to nanotube tips; blocking LFA-1-ICAM or 2B4-CD48 interactions does not block nanotube formation, indicating specificity for CD2.","method":"YTS NK cell line with stable CD2 expression, anti-CD2/CD58 blocking, live-cell fluorescence microscopy, cytotoxicity assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — stable cell line reconstitution with receptor-specific blocking, single lab","pmids":["23112830"],"is_preprint":false},{"year":2006,"finding":"Salt bridges between CD2 and CD58 primarily determine tensile strength of the CD2-CD58 adhesive bond; specific charge mutations (D31A, K41A, K51A, K91A in CD2) reduce equilibrium binding affinity and adhesion strength, confirmed by surface plasmon resonance and surface force apparatus measurements.","method":"Site-directed mutagenesis, surface plasmon resonance, surface force apparatus adhesion measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with quantitative biophysical binding and force measurements","pmids":["17172599"],"is_preprint":false}],"current_model":"CD2 is a T/NK cell surface glycoprotein that functions as an adhesion and co-stimulatory receptor by binding CD58 (humans) or CD48 (rodents) in both trans (on APCs) and cis (on the same T cell) configurations; its low-affinity extracellular Ig domain interaction is amplified by lateral receptor mobility and N-glycosylation-dependent domain stability, while its proline-rich cytoplasmic tail recruits a signaling complex including CD3ζ, p59fyn, p56lck, PLCγ1, and adaptors (CD2BP2, p62dok), enabling CD2 to position itself in the outer 'corolla' of the immunological synapse to boost TCR/SFK/LAT/PLCγ1 signaling, with PD-1 counteracting this amplification, and to promote T cell polarization, nanotube formation, and scanning of APC surfaces."},"narrative":{"teleology":[{"year":1987,"claim":"Identifying CD58 (LFA-3) as the counter-receptor for CD2 established the molecular basis of the T cell adhesion pathway and showed that this interaction provides a co-stimulatory signal for T cell activation.","evidence":"cDNA cloning and expression of LFA-3, functional adhesion assays, and T cell activation with anti-CD2 mAbs plus natural ligand","pmids":["3313052","3102975"],"confidence":"High","gaps":["Stoichiometry of CD2-CD58 interaction on cell surfaces unknown","Structural basis of binding not yet resolved","Relative contribution versus TCR/CD3 not quantified"]},{"year":1989,"claim":"Mapping the LFA-3 binding site to the N-terminal Ig domain of CD2 (Kd ~0.4 µM) and showing independence from the cytoplasmic tail defined CD2 as a modular receptor with separable adhesion and signaling functions.","evidence":"Baculovirus-expressed truncated CD2 fragments, circular dichroism, binding assays","pmids":["2576417","2466941"],"confidence":"High","gaps":["Atomic structure of CD2 domain 1 not yet determined","Whether post-translational modifications regulate binding affinity unresolved"]},{"year":1988,"claim":"Demonstrating that CD2 signaling requires CD3ζ expression established that CD2 does not signal autonomously but is coupled to the TCR/CD3 complex.","evidence":"CD3-deficient Jurkat mutants reconstituted by CD3ζ transfection; Ca²⁺, phosphoinositide, and IL-2 readouts","pmids":["2901344"],"confidence":"High","gaps":["Physical nature of CD2–CD3ζ coupling not identified","Whether coupling is direct or via intermediates unknown"]},{"year":1990,"claim":"Physical association of CD2 with CD45 phosphatase suggested a mechanism for how CD2 engagement modulates tyrosine phosphorylation cascades at the T cell surface.","evidence":"Chemical crosslinking and co-immunoprecipitation in human and mouse T lymphocytes","pmids":["1970422","1980615"],"confidence":"High","gaps":["Functional consequence of CD45 dissociation from CD2 not tested genetically","Whether CD45 dephosphorylates CD2-associated kinases directly unclear"]},{"year":1991,"claim":"Showing that CD2 adhesion is constitutively active while LFA-1 requires TCR activation positioned CD2 as the initiator of T cell–APC contact, and demonstrating that lateral membrane mobility of both CD2 and GPI-anchored LFA-3 amplifies adhesion explained how a low-affinity interaction achieves functional binding.","evidence":"Cell adhesion assays across activation states; reconstituted planar lipid bilayers with FRAP and laminar flow","pmids":["1672642","1717480"],"confidence":"High","gaps":["In vivo relevance of GPI vs. transmembrane LFA-3 isoforms not established","Role of cytoskeletal anchoring of CD2 in mobility regulation not defined"]},{"year":1992,"claim":"Multiple concurrent discoveries refined CD2 structure-function: CD3ζ cytoplasmic domain was shown to be necessary and sufficient for CD2 signal coupling; TCR crosslinking was found to upregulate CD2 avidity via its cytoplasmic C-terminus; and N-glycosylation at Asn65 was established as essential for domain 1 stability and ligand binding.","evidence":"CD8α/CD3ζ chimera reconstitution in CD3-deficient Jurkat; CD2 cytoplasmic tail mutagenesis with CD58 binding assays; Asn65Gln mutagenesis with mass spectrometry","pmids":["1351920","1353888","1385399"],"confidence":"High","gaps":["Structural mechanism of avidity regulation unknown","Whether glycosylation directly contacts LFA-3 or acts indirectly via folding not resolved"]},{"year":1993,"claim":"Identification of CD48 as the rodent CD2 ligand with low-affinity direct binding via domain 1 extended the CD2 adhesion paradigm to rodent models used in subsequent knockout studies.","evidence":"Soluble CD48-CD4 chimera binding, sucrose gradient ultracentrifugation, bacterially expressed CD2 domain 1","pmids":["8099016"],"confidence":"High","gaps":["Whether CD48 and CD58 use identical binding surfaces on CD2 not confirmed","Glycosylation independence for CD48 binding contrasts with CD58 requirement—mechanistic basis unclear"]},{"year":1994,"claim":"Identification of a physical CD2–CD3ζ–p59fyn–p56lck signaling complex provided the first molecular framework for how CD2 engagement activates Src-family kinases.","evidence":"Co-immunoprecipitation, in vitro kinase assays, double immunofluorescence capping in T cells","pmids":["7912674"],"confidence":"High","gaps":["Direct vs. indirect association among complex members not resolved","Relative kinase contributions not yet determined"]},{"year":1998,"claim":"Discovery of CD2BP2 binding to proline-rich PPPGHR motifs via a GYF domain revealed a cytoplasmic adaptor mechanism for CD2-specific signal enhancement, while demonstration of lck-independent JNK/AP-1 activation defined an alternative CD2 signaling branch.","evidence":"Yeast two-hybrid, NMR of GYF domain, IL-2 reporter in Jurkat; JNK assays in lck-deficient Jurkat lines","pmids":["9843987","9727049"],"confidence":"High","gaps":["Physiological role of CD2BP2 in primary T cells not tested","Upstream activator of JNK in CD2 pathway unidentified"]},{"year":1999,"claim":"CD2 knockout mice revealed that CD2 sets a quantitative antigen sensitivity threshold: CD2-deficient T cells require 3–10-fold more antigen for equivalent activation, establishing CD2's non-redundant costimulatory role in vivo.","evidence":"CD2 KO × TCR-transgenic mice, dose-response proliferation, conjugate formation, Ca²⁺ flux","pmids":["10562314"],"confidence":"High","gaps":["In vivo infection or autoimmune phenotypes of CD2 KO not characterized","Compensation by LFA-1 pathway quantified only additively in vitro"]},{"year":2000,"claim":"Genetic studies using fyn−/− mice and CD2/CD28 double knockouts established p59fyn as the critical upstream kinase for CD2 (regulating PLC-γ1, Vav, PKC-θ, Dok, FAK, Pyk2) and showed CD2 and CD28 coordinately facilitate T cell–APC interaction.","evidence":"fyn−/− mice with hCD2 transgene; CD2/CD28 double KO mice; Ca²⁺, MAPK, substrate phosphorylation assays","pmids":["11093170","10725714"],"confidence":"High","gaps":["Whether fyn is required cell-autonomously for CD2 signaling in all T cell subsets unknown","Redundancy between CD2 and CD28 at the molecular signaling level not dissected"]},{"year":2001,"claim":"CD2 was shown to be inducibly recruited to lipid rafts upon engagement (requiring ectodomain conformational change), while p62dok was identified as a CD2-specific negative regulator that inhibits PLC-γ1 and ERK1/2 downstream of CD2 but not CD3.","evidence":"Lipid raft fractionation with cholesterol depletion and CD2 mutants; p62dok overexpression in Jurkat with Ca²⁺, PLC-γ1, ERK readouts","pmids":["11376005","11254695"],"confidence":"High","gaps":["Raft recruitment kinetics in primary T cells not measured","Physiological relevance of p62dok regulation of CD2 not tested in vivo"]},{"year":2002,"claim":"Live-cell imaging revealed that CD2–CD58 engagement induces T cell polarization, uropod enrichment of CD2 (~100-fold), and scanning motility along APCs, establishing CD2 as a driver of T cell morphological dynamics during APC surveillance.","evidence":"Time-lapse DIC and immunofluorescence on living T cells, MLCK and integrin inhibition","pmids":["12032326"],"confidence":"High","gaps":["Whether scanning motility depends on CD2 signaling vs. adhesion alone not separated","In vivo relevance of uropod CD2 enrichment unconfirmed"]},{"year":2006,"claim":"Biophysical dissection of CD2–CD58 bonds identified salt bridges as the primary determinants of tensile strength, and CD2 was found to promote membrane nanotube formation between NK cells and targets.","evidence":"Surface plasmon resonance and surface force apparatus with charge-reversal mutants; live-cell fluorescence of YTS NK cells with anti-CD2/CD58 blocking","pmids":["17172599","23112830"],"confidence":"High","gaps":["Nanotube finding from a single NK cell line with overexpressed CD2","Whether nanotube formation is relevant to T cells not tested"]},{"year":2007,"claim":"Single-cell imaging showed CD2–CD58 interaction at the immunological synapse sustains antigen-induced Ca²⁺ signals and is required for PLC-γ1 recruitment and Tyr783 phosphorylation at the IS, establishing the biochemical convergence point of TCR and CD2 signaling.","evidence":"Single-cell Ca²⁺ imaging, IS immunofluorescence, PLC-γ1 phospho-assays, anti-CD58 blocking","pmids":["17220479"],"confidence":"High","gaps":["Whether PLC-γ1 recruitment is via direct CD2 interaction or via LAT scaffolding not resolved"]},{"year":2008,"claim":"Nanoscale elongation of the CD2–CD48 intermembrane distance by 2–4 nm reduced adhesion 10-fold and reorganized the IS, revealing that precise intermembrane spacing is a critical biophysical parameter for CD2 function.","evidence":"Electron tomography, CD48 Ig-domain extension chimeras, primary T cell activation assays","pmids":["18826951"],"confidence":"High","gaps":["Whether spacing effects apply identically to CD2–CD58 in human system not tested"]},{"year":2009,"claim":"Reconstituted bilayer and co-IP studies demonstrated that CD2 engagement alone nucleates TCR-ζ/Lck/LAT microclusters before TCR triggering, and that CD48 hierarchically shuttles LAT to the TCR/CD3 complex in a CD2-dependent manner.","evidence":"Single-molecule fluorescence on planar bilayers (Jurkat); co-IP with CD48 knockdown, LAT/Lck recruitment assays","pmids":["19398758","19494291"],"confidence":"High","gaps":["Whether pre-formed CD2 microclusters are present in primary T cells in vivo unknown","Molecular basis of CD2-dependent LAT shuttling by CD48 not identified"]},{"year":2020,"claim":"Super-resolution imaging defined the 'CD2 corolla' at the outer immunological synapse where CD2–CD58 amplifies SFK/LAT/PLC-γ signaling by ~77% over central contacts; PD-1 invades this corolla to buffer signal amplification, providing a spatial mechanism for checkpoint inhibition of CD2-augmented TCR signaling.","evidence":"Super-resolution and confocal imaging with cellular and artificial APCs, genetic CD2 mutants, phospho-signaling measurements in primary T cells","pmids":["32929275"],"confidence":"High","gaps":["Whether corolla disruption fully accounts for PD-1 inhibitory function unknown","Contribution of individual cytoplasmic tail motifs to corolla architecture incompletely mapped"]},{"year":2022,"claim":"FRET-based detection of cis CD2–CD48 interactions on the same T cell, combined with knockout epistasis showing T cell-intrinsic CD48 is required for TCR signaling, overturned the purely trans-interaction model and revealed that CD2 functions through both cis and trans ligand engagement.","evidence":"FRET in nonimmune cells, CD2/CD48 KO mice, CD2 knock-in tag mass spectrometry, PTK and cytotoxicity assays","pmids":["35930657"],"confidence":"High","gaps":["Structural basis of cis vs. trans binding not determined","Whether cis interaction occurs with CD58 in human T cells not addressed","Relative signaling contribution of cis vs. trans engagement not quantified"]},{"year":null,"claim":"The structural basis of CD2 corolla formation, the atomic mechanism by which cis CD2–ligand interactions promote TCR signaling, and how CD2 integrates with checkpoint receptors beyond PD-1 remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of CD2 in a cis complex","Mechanism of PD-1 invasion into the CD2 corolla not defined at molecular level","Role of CD2 in non-conventional T cell subsets (γδ, NKT) mechanistically uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,6,29]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[12,22,23]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,5,16,18,23,24]}],"pathway":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,3,14,23,27]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,11,15,19,23]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,6,18,20]}],"complexes":["TCR/CD3 signaling complex"],"partners":["CD58","CD48","CD247","FYN","LCK","CD2BP2","PTPRC","DOK1"],"other_free_text":[]},"mechanistic_narrative":"CD2 is a T and NK cell surface glycoprotein of the immunoglobulin superfamily that functions as a constitutive adhesion receptor and co-stimulatory signal amplifier, lowering the antigen dose threshold for T cell activation. Its N-terminal Ig domain binds CD58 (human) or CD48 (rodent) with low micromolar affinity stabilized by N-glycosylation at Asn65 and salt bridges at the binding interface; lateral receptor mobility on the membrane amplifies this weak interaction into effective cell-cell adhesion [PMID:3313052, PMID:1717480, PMID:1385399, PMID:17172599]. The proline-rich cytoplasmic tail recruits a signaling complex including CD3ζ, p59fyn, p56lck, and adaptor CD2BP2, coupling CD2 to PLC-γ1 phosphorylation, Ca²⁺ mobilization, and MAPK activation—with p59fyn serving as the critical upstream kinase and p62dok acting as a negative regulator—while CD2 also engages in cis interactions with CD48 on the same T cell to support TCR signaling [PMID:1351920, PMID:7912674, PMID:11093170, PMID:9843987, PMID:11254695, PMID:35930657]. At the immunological synapse, CD2 localizes to an outer corolla where it captures co-stimulatory receptors and amplifies SFK/LAT/PLC-γ1 signaling by ~77% compared to centrally positioned CD2–CD58 contacts, a function counteracted by PD-1 invasion of this domain [PMID:32929275, PMID:19398758]."},"prefetch_data":{"uniprot":{"accession":"P06729","full_name":"T-cell surface antigen CD2","aliases":["Erythrocyte receptor","LFA-2","LFA-3 receptor","Rosette receptor","T-cell surface antigen T11/Leu-5"],"length_aa":351,"mass_kda":39.4,"function":"CD2 interacts with lymphocyte function-associated antigen CD58 (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells and other cell types. CD2 is implicated in the triggering of T-cells, the cytoplasmic domain is implicated in the signaling function","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P06729/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD2","total_profiled":1310},"omim":[{"mim_id":"616714","title":"HMG-BOX TRANSCRIPTION FACTOR 1; HBP1","url":"https://www.omim.org/entry/616714"},{"mim_id":"615707","title":"IMMUNODEFICIENCY 20; IMD20","url":"https://www.omim.org/entry/615707"},{"mim_id":"615615","title":"IMMUNODEFICIENCY 18; IMD18","url":"https://www.omim.org/entry/615615"},{"mim_id":"615122","title":"LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2","url":"https://www.omim.org/entry/615122"},{"mim_id":"612268","title":"TUBULIN TYROSINE LIGASE-LIKE 5; TTLL5","url":"https://www.omim.org/entry/612268"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":232.5}],"url":"https://www.proteinatlas.org/search/CD2"},"hgnc":{"alias_symbol":[],"prev_symbol":["SRBC"]},"alphafold":{"accession":"P06729","domains":[{"cath_id":"2.60.40.10","chopping":"26-126","consensus_level":"high","plddt":94.4352,"start":26,"end":126},{"cath_id":"2.60.40.10","chopping":"133-202","consensus_level":"high","plddt":96.2903,"start":133,"end":202},{"cath_id":"1.20.5","chopping":"207-244","consensus_level":"medium","plddt":85.5232,"start":207,"end":244}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P06729","model_url":"https://alphafold.ebi.ac.uk/files/AF-P06729-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P06729-F1-predicted_aligned_error_v6.png","plddt_mean":77.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD2","jax_strain_url":"https://www.jax.org/strain/search?query=CD2"},"sequence":{"accession":"P06729","fasta_url":"https://rest.uniprot.org/uniprotkb/P06729.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P06729/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P06729"}},"corpus_meta":[{"pmid":"3313052","id":"PMC_3313052","title":"An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3313052","citation_count":742,"is_preprint":false},{"pmid":"3102975","id":"PMC_3102975","title":"Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3102975","citation_count":275,"is_preprint":false},{"pmid":"1970422","id":"PMC_1970422","title":"Association of CD2 and CD45 on human T lymphocytes.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1970422","citation_count":184,"is_preprint":false},{"pmid":"1717480","id":"PMC_1717480","title":"Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1717480","citation_count":173,"is_preprint":false},{"pmid":"19262564","id":"PMC_19262564","title":"SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19262564","citation_count":169,"is_preprint":false},{"pmid":"2576417","id":"PMC_2576417","title":"The structural biology of CD2.","date":"1989","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/2576417","citation_count":161,"is_preprint":false},{"pmid":"11698418","id":"PMC_11698418","title":"Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11698418","citation_count":159,"is_preprint":false},{"pmid":"2901344","id":"PMC_2901344","title":"Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2901344","citation_count":153,"is_preprint":false},{"pmid":"1358605","id":"PMC_1358605","title":"Development and function of T cells in mice with a disrupted CD2 gene.","date":"1992","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1358605","citation_count":143,"is_preprint":false},{"pmid":"2427570","id":"PMC_2427570","title":"T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2.","date":"1986","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2427570","citation_count":137,"is_preprint":false},{"pmid":"32582179","id":"PMC_32582179","title":"CD2 Immunobiology.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32582179","citation_count":121,"is_preprint":false},{"pmid":"25990730","id":"PMC_25990730","title":"Rational evolution of Cd2+-specific DNAzymes with phosphorothioate modified cleavage junction and Cd2+ sensing.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25990730","citation_count":111,"is_preprint":false},{"pmid":"12213321","id":"PMC_12213321","title":"CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function.","date":"2002","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12213321","citation_count":110,"is_preprint":false},{"pmid":"17075075","id":"PMC_17075075","title":"Proteome changes in Arabidopsis thaliana roots upon exposure to Cd2+.","date":"2006","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/17075075","citation_count":108,"is_preprint":false},{"pmid":"2462499","id":"PMC_2462499","title":"Unusual expression of CD2 in sheep: implications for T cell interactions.","date":"1988","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2462499","citation_count":106,"is_preprint":false},{"pmid":"7525835","id":"PMC_7525835","title":"CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.","date":"1994","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7525835","citation_count":104,"is_preprint":false},{"pmid":"32929275","id":"PMC_32929275","title":"A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.","date":"2020","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32929275","citation_count":103,"is_preprint":false},{"pmid":"1682413","id":"PMC_1682413","title":"Anti-CD2 antibodies induce T cell unresponsiveness in vivo.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1682413","citation_count":100,"is_preprint":false},{"pmid":"10562314","id":"PMC_10562314","title":"CD2 sets quantitative thresholds in T cell activation.","date":"1999","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10562314","citation_count":99,"is_preprint":false},{"pmid":"1385156","id":"PMC_1385156","title":"CD59 molecule: a second ligand for CD2 in T cell adhesion.","date":"1992","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1385156","citation_count":98,"is_preprint":false},{"pmid":"1353379","id":"PMC_1353379","title":"Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia.","date":"1992","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/1353379","citation_count":97,"is_preprint":false},{"pmid":"11691816","id":"PMC_11691816","title":"Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11691816","citation_count":92,"is_preprint":false},{"pmid":"19398758","id":"PMC_19398758","title":"The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19398758","citation_count":89,"is_preprint":false},{"pmid":"9843987","id":"PMC_9843987","title":"Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9843987","citation_count":88,"is_preprint":false},{"pmid":"1672642","id":"PMC_1672642","title":"Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation.","date":"1991","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1672642","citation_count":80,"is_preprint":false},{"pmid":"1351920","id":"PMC_1351920","title":"The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation.","date":"1992","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1351920","citation_count":74,"is_preprint":false},{"pmid":"8099016","id":"PMC_8099016","title":"The NH2-terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2.","date":"1993","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8099016","citation_count":73,"is_preprint":false},{"pmid":"4913802","id":"PMC_4913802","title":"Peritoneal macrophages in the immune response to SRBC in vitro.","date":"1970","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/4913802","citation_count":73,"is_preprint":false},{"pmid":"24273214","id":"PMC_24273214","title":"Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer.","date":"2013","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/24273214","citation_count":68,"is_preprint":false},{"pmid":"2466941","id":"PMC_2466941","title":"Structural and binding analysis of a two domain extracellular CD2 molecule.","date":"1989","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2466941","citation_count":67,"is_preprint":false},{"pmid":"12031800","id":"PMC_12031800","title":"Studies on the interaction between Cd(2+) ions and DNA.","date":"2002","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12031800","citation_count":64,"is_preprint":false},{"pmid":"15800069","id":"PMC_15800069","title":"Clues to CD2-associated protein involvement in cytokinesis.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15800069","citation_count":63,"is_preprint":false},{"pmid":"14643126","id":"PMC_14643126","title":"CD2-associated protein and glomerular disease.","date":"2003","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14643126","citation_count":62,"is_preprint":false},{"pmid":"18826951","id":"PMC_18826951","title":"Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18826951","citation_count":58,"is_preprint":false},{"pmid":"10725714","id":"PMC_10725714","title":"Coordinate regulation of T cell activation by CD2 and CD28.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10725714","citation_count":57,"is_preprint":false},{"pmid":"1353888","id":"PMC_1353888","title":"A distinct cytoplasmic domain of CD2 regulates ligand avidity and T-cell responsiveness to antigen.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1353888","citation_count":56,"is_preprint":false},{"pmid":"11313408","id":"PMC_11313408","title":"Cloning, expression, and function of BLAME, a novel member of the CD2 family.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11313408","citation_count":54,"is_preprint":false},{"pmid":"22222639","id":"PMC_22222639","title":"Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.","date":"2012","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/22222639","citation_count":54,"is_preprint":false},{"pmid":"1385399","id":"PMC_1385399","title":"N-glycosylation is required for human CD2 immunoadhesion functions.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1385399","citation_count":53,"is_preprint":false},{"pmid":"7729601","id":"PMC_7729601","title":"Mammalian CD2 is an effective heterologous marker of the cell surface in Drosophila.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7729601","citation_count":52,"is_preprint":false},{"pmid":"15951437","id":"PMC_15951437","title":"CD2-associated protein (CD2AP) expression in podocytes rescues lethality of CD2AP deficiency.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15951437","citation_count":50,"is_preprint":false},{"pmid":"1381388","id":"PMC_1381388","title":"Mechanism of peripheral T cell activation by coengagement of CD44 and CD2.","date":"1992","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1381388","citation_count":50,"is_preprint":false},{"pmid":"1674520","id":"PMC_1674520","title":"CD2 can mediate TCR/CD3-independent T cell activation.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1674520","citation_count":49,"is_preprint":false},{"pmid":"2895149","id":"PMC_2895149","title":"Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation.","date":"1988","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2895149","citation_count":48,"is_preprint":false},{"pmid":"11376005","id":"PMC_11376005","title":"Dynamic recruitment of human CD2 into lipid rafts. Linkage to T cell signal transduction.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11376005","citation_count":46,"is_preprint":false},{"pmid":"12668431","id":"PMC_12668431","title":"Forced detachment of the CD2-CD58 complex.","date":"2003","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12668431","citation_count":45,"is_preprint":false},{"pmid":"12032326","id":"PMC_12032326","title":"CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12032326","citation_count":45,"is_preprint":false},{"pmid":"2458944","id":"PMC_2458944","title":"CD4+CD45R+ cells are preferentially activated through the CD2 pathway.","date":"1988","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2458944","citation_count":45,"is_preprint":false},{"pmid":"35930657","id":"PMC_35930657","title":"Cis interactions between CD2 and its ligands on T cells are required for T cell activation.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35930657","citation_count":44,"is_preprint":false},{"pmid":"2575032","id":"PMC_2575032","title":"Expression and function of CD2 during murine thymocyte ontogeny.","date":"1989","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2575032","citation_count":44,"is_preprint":false},{"pmid":"2565352","id":"PMC_2565352","title":"Distribution and ontogeny of CD2 expression by murine T cells.","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2565352","citation_count":42,"is_preprint":false},{"pmid":"8102249","id":"PMC_8102249","title":"CD2 expression on murine intestinal intraepithelial lymphocytes is bimodal and defines proliferative capacity.","date":"1993","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8102249","citation_count":41,"is_preprint":false},{"pmid":"2894031","id":"PMC_2894031","title":"Exon-intron organization and sequence comparison of human and murine T11 (CD2) genes.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2894031","citation_count":41,"is_preprint":false},{"pmid":"19494291","id":"PMC_19494291","title":"Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19494291","citation_count":40,"is_preprint":false},{"pmid":"7693022","id":"PMC_7693022","title":"T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2.","date":"1993","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7693022","citation_count":39,"is_preprint":false},{"pmid":"17168569","id":"PMC_17168569","title":"Mechanisms of Cellular Avidity Regulation in CD2-CD58-Mediated T Cell Adhesion.","date":"2006","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/17168569","citation_count":39,"is_preprint":false},{"pmid":"18958723","id":"PMC_18958723","title":"Primary immune response to sheep red blood cells (SRBC) as the conventional T-cell dependent antibody response (TDAR) test.","date":"2007","source":"Journal of immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/18958723","citation_count":39,"is_preprint":false},{"pmid":"9282312","id":"PMC_9282312","title":"Cadmium (Cd2+) disrupts E-cadherin-dependent cell-cell junctions in MDCK cells.","date":"1997","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/9282312","citation_count":38,"is_preprint":false},{"pmid":"7912674","id":"PMC_7912674","title":"Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7912674","citation_count":38,"is_preprint":false},{"pmid":"11132158","id":"PMC_11132158","title":"Ly108: a new member of the mouse CD2 family of cell surface proteins.","date":"2000","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11132158","citation_count":38,"is_preprint":false},{"pmid":"17161298","id":"PMC_17161298","title":"Use of SRBC antibody responses for immunotoxicity testing.","date":"2007","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/17161298","citation_count":36,"is_preprint":false},{"pmid":"17220479","id":"PMC_17220479","title":"CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse.","date":"2007","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17220479","citation_count":36,"is_preprint":false},{"pmid":"21094032","id":"PMC_21094032","title":"The role of SLAM/CD2 polymorphisms in systemic autoimmunity.","date":"2010","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21094032","citation_count":35,"is_preprint":false},{"pmid":"1089715","id":"PMC_1089715","title":"Suppression and enhancement of the T cell-dependent production of antibody to SRBC in vitro by bacterial lipopolysaccharide.","date":"1975","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1089715","citation_count":35,"is_preprint":false},{"pmid":"1691222","id":"PMC_1691222","title":"Expression and ontogeny of CD2 on murine B cells.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1691222","citation_count":34,"is_preprint":false},{"pmid":"27337048","id":"PMC_27337048","title":"Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.","date":"2016","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/27337048","citation_count":33,"is_preprint":false},{"pmid":"2577288","id":"PMC_2577288","title":"CD2 expression in murine B cell lineage.","date":"1989","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2577288","citation_count":32,"is_preprint":false},{"pmid":"2569403","id":"PMC_2569403","title":"Expression and ontogeny of murine CD2.","date":"1989","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2569403","citation_count":32,"is_preprint":false},{"pmid":"11093170","id":"PMC_11093170","title":"A critical role for p59(fyn) in CD2-based signal transduction.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11093170","citation_count":32,"is_preprint":false},{"pmid":"1980615","id":"PMC_1980615","title":"Association of CD2 and T200 (CD45) in mouse T lymphocytes.","date":"1990","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1980615","citation_count":32,"is_preprint":false},{"pmid":"2567676","id":"PMC_2567676","title":"The effects of anti-CD2 antibodies on the differentiation of mouse thymocytes.","date":"1989","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2567676","citation_count":32,"is_preprint":false},{"pmid":"11254695","id":"PMC_11254695","title":"p62dok negatively regulates CD2 signaling in Jurkat cells.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11254695","citation_count":31,"is_preprint":false},{"pmid":"8757956","id":"PMC_8757956","title":"An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro.","date":"1996","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8757956","citation_count":31,"is_preprint":false},{"pmid":"16913869","id":"PMC_16913869","title":"Sulphate assimilation under Cd2+ stress in Physcomitrella patens--combined transcript, enzyme and metabolite profiling.","date":"2006","source":"Plant, cell & environment","url":"https://pubmed.ncbi.nlm.nih.gov/16913869","citation_count":30,"is_preprint":false},{"pmid":"16323413","id":"PMC_16323413","title":"The CD2 family of natural killer cell receptors.","date":"2006","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16323413","citation_count":29,"is_preprint":false},{"pmid":"16982875","id":"PMC_16982875","title":"A large T cell invagination with CD2 enrichment resets receptor engagement in the immunological synapse.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16982875","citation_count":29,"is_preprint":false},{"pmid":"2567000","id":"PMC_2567000","title":"Chromatin configuration of the human CD2 gene locus during T-cell development.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2567000","citation_count":29,"is_preprint":false},{"pmid":"26841241","id":"PMC_26841241","title":"MYO3A Causes Human Dominant Deafness and Interacts with Protocadherin 15-CD2 Isoform.","date":"2016","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/26841241","citation_count":29,"is_preprint":false},{"pmid":"1684171","id":"PMC_1684171","title":"Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.","date":"1991","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1684171","citation_count":28,"is_preprint":false},{"pmid":"1673843","id":"PMC_1673843","title":"Defective CD2 pathway T cell activation in systemic lupus erythematosus.","date":"1991","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/1673843","citation_count":28,"is_preprint":false},{"pmid":"1706751","id":"PMC_1706751","title":"T cell receptor-independent CD2 signal transduction in FcR+ cells.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1706751","citation_count":25,"is_preprint":false},{"pmid":"19586919","id":"PMC_19586919","title":"Inhibition and activation by CD244 depends on CD2 and phospholipase C-gamma1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19586919","citation_count":25,"is_preprint":false},{"pmid":"10510361","id":"PMC_10510361","title":"CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10510361","citation_count":25,"is_preprint":false},{"pmid":"22973059","id":"PMC_22973059","title":"Cd²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for Cd²⁺ influx.","date":"2012","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22973059","citation_count":25,"is_preprint":false},{"pmid":"9565369","id":"PMC_9565369","title":"Activation-induced NK cell death triggered by CD2 stimulation.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9565369","citation_count":25,"is_preprint":false},{"pmid":"11195047","id":"PMC_11195047","title":"CD2-associated protein and the kidney.","date":"2001","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/11195047","citation_count":24,"is_preprint":false},{"pmid":"1384685","id":"PMC_1384685","title":"Expression of the CD2 molecule on human B lymphoid progenitors.","date":"1992","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1384685","citation_count":24,"is_preprint":false},{"pmid":"2895712","id":"PMC_2895712","title":"Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression.","date":"1988","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2895712","citation_count":23,"is_preprint":false},{"pmid":"23112830","id":"PMC_23112830","title":"CD2 promotes human natural killer cell membrane nanotube formation.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23112830","citation_count":22,"is_preprint":false},{"pmid":"18177421","id":"PMC_18177421","title":"CD2-associated protein is widely expressed and differentially regulated during embryonic development.","date":"2008","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/18177421","citation_count":22,"is_preprint":false},{"pmid":"2903216","id":"PMC_2903216","title":"Identification of CD2-/CD3+ T cells in fetal human tissue.","date":"1988","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2903216","citation_count":22,"is_preprint":false},{"pmid":"26584949","id":"PMC_26584949","title":"CD2-associated protein participates in podocyte apoptosis via PI3K/Akt signaling pathway.","date":"2015","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/26584949","citation_count":21,"is_preprint":false},{"pmid":"9727049","id":"PMC_9727049","title":"A p56lck-independent pathway of CD2 signaling involves Jun kinase.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9727049","citation_count":21,"is_preprint":false},{"pmid":"17009132","id":"PMC_17009132","title":"Simultaneous Cd2+, Zn2+, and Pb2+ uptake and accumulation by photosynthetic Euglena gracilis.","date":"2006","source":"Archives of environmental contamination and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/17009132","citation_count":21,"is_preprint":false},{"pmid":"1370253","id":"PMC_1370253","title":"Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins.","date":"1992","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1370253","citation_count":21,"is_preprint":false},{"pmid":"17172599","id":"PMC_17172599","title":"Impact of salt bridges on the equilibrium binding and adhesion of human CD2 and CD58.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17172599","citation_count":21,"is_preprint":false},{"pmid":"7717877","id":"PMC_7717877","title":"Stimulation of myosin light-chain kinase by Cd2+ and Pb2+.","date":"1995","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/7717877","citation_count":20,"is_preprint":false},{"pmid":"12356317","id":"PMC_12356317","title":"Direct measurements of heterotypic adhesion between the cell surface proteins CD2 and CD48.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12356317","citation_count":20,"is_preprint":false},{"pmid":"28191954","id":"PMC_28191954","title":"Glycosylation and Lipids Working in Concert Direct CD2 Ectodomain Orientation and Presentation.","date":"2017","source":"The journal of physical chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/28191954","citation_count":19,"is_preprint":false},{"pmid":"35972421","id":"PMC_35972421","title":"AtPRMT5-mediated AtLCD methylation improves Cd2+ tolerance via increased H2S production in Arabidopsis.","date":"2022","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35972421","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43433,"output_tokens":6744,"usd":0.115729},"stage2":{"model":"claude-opus-4-6","input_tokens":10467,"output_tokens":4582,"usd":0.250327},"total_usd":0.366056,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"LFA-3 (CD58) was identified as the physiological cell-surface ligand for CD2; LFA-3 cDNA encodes a phospholipid-linked (GPI-anchored) membrane protein whose extracellular domain shares homology with CD2, and CD2-LFA-3 interaction mediates T cell adhesion and conjugate formation.\",\n      \"method\": \"cDNA cloning, transient expression system, functional adhesion assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original ligand identification by cDNA cloning and expression, foundational paper with >700 citations\",\n      \"pmids\": [\"3313052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"Binding of LFA-3 (T11 target structure) to CD2 on T cells provides one of the signals required for alternative pathway T cell activation, rendering resting T cells responsive to mitogenic anti-CD2 stimuli.\",\n      \"method\": \"Functional T cell activation assays with natural ligand and anti-CD2 mAbs\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct ligand-receptor functional assay, >275 citations\",\n      \"pmids\": [\"3102975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"The extracellular domain of CD2 is organized in two Ig-like domains; the NH2-terminal domain (exon 2, ~103 aa) is sufficient for LFA-3 binding with a Kd of ~0.4 µM, is resistant to proteolysis despite lacking intrachain disulfides, and ligand binding is not regulated by the cytoplasmic domain.\",\n      \"method\": \"Baculovirus and eukaryotic expression of recombinant CD2 fragments, circular dichroism, binding assays, truncation mutagenesis\",\n      \"journal\": \"Immunological reviews / The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — recombinant protein binding assay with mutagenesis, replicated in multiple papers\",\n      \"pmids\": [\"2576417\", \"2466941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"CD2 activation pathway is interdependent with CD3-Ti: Jurkat mutants lacking surface CD3-Ti fail to be activated through CD2 (no phosphoinositide turnover, Ca2+ mobilization, or IL-2 induction), and CD3-Ti re-expression restores CD2-mediated signaling.\",\n      \"method\": \"Jurkat mutant cell lines, DNA transfection reconstitution, phosphoinositide turnover, Ca2+ mobilization assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic reconstitution epistasis in defined mutant cell lines, replicated\",\n      \"pmids\": [\"2901344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CD2 is physically associated with CD45 (T200, leukocyte common antigen) on the surface of human and mouse T lymphocytes, as demonstrated by chemical cross-linking and co-immunoprecipitation; CD45 tyrosine phosphatase activity may explain CD45's co-mitogenic effect with anti-CD2 antibodies.\",\n      \"method\": \"Chemical crosslinking, co-immunoprecipitation, co-precipitation from detergent lysates\",\n      \"journal\": \"Nature / International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-precipitation and crosslinking, replicated in two independent labs (human and mouse)\",\n      \"pmids\": [\"1970422\", \"1980615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"CD2 adhesion function is constitutively active in resting T cells and is not upregulated by TCR stimulation, in contrast to LFA-1 whose adhesion is minimal at rest and rapidly augmented by TCR-mediated activation; this complementarity positions CD2 to initiate cell-cell contact before TCR engagement.\",\n      \"method\": \"Cell adhesion assays, PKC activation, cAMP manipulation, surface redistribution analysis\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological perturbations across activation states, >80 citations\",\n      \"pmids\": [\"1672642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Lateral mobility of LFA-3 and CD2 on membranes enhances adhesion strengthening; GPI-anchored LFA-3 (mobile) supports faster adhesion strengthening than transmembrane LFA-3 (immobile), and reducing CD2 mobility decreases adhesion strengthening rate.\",\n      \"method\": \"Reconstituted planar lipid bilayers, static and laminar flow adhesion assays, fluorescence recovery after photobleaching\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted bilayer system with quantitative adhesion measurement, >170 citations\",\n      \"pmids\": [\"1717480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The CD3 zeta cytoplasmic domain is necessary and sufficient to couple CD2 to intracellular signal transduction (Ca2+ mobilization, protein tyrosine kinase activation, IL-2 secretion) in Jurkat cells lacking CD3-Ti, established by a CD8α/CD3ζ chimeric receptor transfection.\",\n      \"method\": \"Chimeric cDNA transfection into CD3-deficient Jurkat variants, Ca2+ measurement, PTK assay, IL-2 ELISA\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with defined chimeric protein, specific gain-of-function\",\n      \"pmids\": [\"1351920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"TCR-CD3 crosslinking rapidly increases CD2 avidity for CD58 (LFA-3); mutational analysis of the CD2 cytoplasmic domain shows the carboxyl-terminal asparagine is essential for avidity regulation but not for CD2-mediated signaling, defining structurally distinct functional domains; loss of avidity regulation impairs antigen-specific T cell responses.\",\n      \"method\": \"Mutational analysis of CD2 cytoplasmic domain, CD58 binding assays, antigen-specific T cell activation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-directed mutagenesis with functional readout, defines discrete domains\",\n      \"pmids\": [\"1353888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"N-glycosylation at Asn65 in domain 1 of CD2 is required for LFA-3 (CD58) binding and for recognition by adhesion-domain-specific anti-CD2 mAbs; high mannose oligosaccharides occupy Asn65; deglycosylation or Asn65Gln mutation abolishes CD2 adhesion function by destabilizing domain 1.\",\n      \"method\": \"Site-directed mutagenesis (Asn65Gln), enzymatic deglycosylation, binding assays, electrospray ionization-mass spectrometry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with structural characterization and functional binding assay\",\n      \"pmids\": [\"1385399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD2 binds CD48 via its NH2-terminal Ig domain in rats (and by analogy mice) with low affinity (Kd upper limit ~2.5 µM); binding does not require glycosylation of CD2 and is direct as shown by solution binding of bacterially expressed domain 1.\",\n      \"method\": \"Soluble chimeric CD48-CD4 protein, rosetting assay, sucrose gradient ultracentrifugation, bacterial expression of CD2 domain 1\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct solution binding assay with recombinant minimal domain\",\n      \"pmids\": [\"8099016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CD2 forms a signaling complex with CD3 zeta chain and the Src-family tyrosine kinases p59fyn and p56lck in T lymphocytes, as identified by co-immunoprecipitation and in vitro kinase assays on CD2 immunoprecipitates; double immunofluorescence confirms the complex in living T cells.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, double indirect immunofluorescence with capping\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with kinase activity assay and orthogonal imaging confirmation\",\n      \"pmids\": [\"7912674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"An intracellular adaptor protein CD2BP2 binds two PPPGHR proline-rich segments in the CD2 cytoplasmic tail via a novel 17-aa GYF motif; overexpression of the CD2BP2 binding domain in Jurkat cells enhances IL-2 production upon CD2 crosslinking but not TCR crosslinking.\",\n      \"method\": \"Yeast two-hybrid, NMR analysis, mutagenesis, Jurkat overexpression with IL-2 reporter\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure + mutagenesis + functional cellular assay in single study\",\n      \"pmids\": [\"9843987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD2 can signal through a p56lck-independent pathway involving Jun kinase activation; CD2-mediated IL-2 production occurs via JNK-dependent AP-1 activation in T cell lines lacking p56lck, whereas TCR-triggered activation requires p56lck.\",\n      \"method\": \"p56lck-deficient Jurkat cell lines, JNK kinase assays, AP-1/IL-2 promoter reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined genetic loss-of-function cell lines with biochemical pathway dissection\",\n      \"pmids\": [\"9727049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD2 sets quantitative activation thresholds; CD2-deficient T cells show a 3–10-fold rightward shift in antigen dose-response in vitro, impaired TCR triggering and Ca2+ flux at low antigen density; CD2 and LFA-1 adhesion pathways function additively.\",\n      \"method\": \"CD2 knockout mice crossed with TCR-transgenic mice, dose-response proliferation assays, conjugate formation, TCR triggering, Ca2+ flux measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple orthogonal readouts and quantitative dose-response\",\n      \"pmids\": [\"10562314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p59fyn is a critical Src-family PTK upstream in the CD2 signaling pathway; in fyn-/- mice expressing transgenic human CD2, CD2-triggered Ca2+ mobilization, MAPK activation and proliferation are markedly reduced, while TCR-triggered proliferation is unaffected; CD2 substrates regulated by fyn include PLC-γ1, Vav, PKC-θ, Dok, FAK and Pyk2.\",\n      \"method\": \"Transgenic human CD2 in fyn-/- mice, Ca2+ mobilization, MAPK assays, substrate phosphorylation analysis\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined genetic KO with multiple biochemical substrates characterized\",\n      \"pmids\": [\"11093170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CD2 is inducibly recruited into lipid raft microdomains upon crosslinking by anti-CD2 mAbs or CD58 engagement; raft integrity is required for CD2-stimulated Ca2+ elevation and tyrosine phosphorylation; translocation requires ectodomain conformational change and is independent of TCR and cytoplasmic tyrosine phosphorylation; murine CD2 partitions constitutively into rafts via membrane-proximal cytoplasmic cysteines absent in human CD2.\",\n      \"method\": \"Lipid raft fractionation, cholesterol depletion, CD2 point mutation/deletion/chimeric constructs, Ca2+ and phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — fractionation with multiple mutants and functional consequences characterized\",\n      \"pmids\": [\"11376005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"p62dok negatively regulates CD2 signaling in Jurkat T cells; overexpression of p62dok inhibits CD2-induced Ca2+ increase, PLC-γ1 activation, and ERK1/2 activation but not CD3/TCR-induced equivalents; CD2 (but not CD3) stimulation induces p62dok and RasGAP recruitment to the plasma membrane.\",\n      \"method\": \"Jurkat overexpression clones, Ca2+ flux, PLC-γ1 and ERK assays, subcellular fractionation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined overexpression with multiple specific biochemical readouts pathway-specifically attributed to CD2\",\n      \"pmids\": [\"11254695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CD2 engagement with CD58 induces T cell polarization and scanning motility along APC surfaces; CD2 molecules rapidly redistribute to the uropod with ~100-fold greater density versus the leading edge; CD2, TCR, and lipid rafts co-compartmentalize in the uropod, forming a 'presynapse'; scanning requires β-integrin function and myosin light chain kinase.\",\n      \"method\": \"Time-lapse DIC and immunofluorescence microscopy on living T cells, pharmacological inhibition\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — live-cell imaging with quantitative redistribution data and pharmacological validation\",\n      \"pmids\": [\"12032326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CD2-CD58 interaction at the immunological synapse augments and sustains antigen-induced Ca2+ increase in individual T cells and is required for PLCγ1 recruitment to the IS and phosphorylation of PLCγ1 at Tyr783; TCR and CD2 signals converge on PLCγ1 activation.\",\n      \"method\": \"Single-cell Ca2+ imaging, IS immunofluorescence, PLCγ1 phosphorylation assays, anti-CD58 blocking\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single cell imaging plus defined biochemical pathway with blocking experiments\",\n      \"pmids\": [\"17220479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Nanoscale increases in CD2-CD48 intermembrane spacing (by 2–4 nm achieved using elongated CD48 chimeras) reduce adhesion efficiency 10-fold and reorganize the immunological synapse; increased spacing causes eccentric CD2/TCR cluster formation and dramatically reduces T cell sensitivity.\",\n      \"method\": \"Electron tomography, confocal imaging, primary T cell activation assays, CD48 Ig-domain extension chimeras\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural measurement by EM tomography with functional consequence in primary cells\",\n      \"pmids\": [\"18826951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD58 ligation of CD2 alone (without TCR activation) induces actin-dependent coalescence of signaling molecules (TCR-ζ, Lck, LAT) into plasma membrane microdomains in Jurkat cells on planar bilayers; CD2 and TCR initially colocalize in microdomains then partition into separate zones enabling synergistic signaling.\",\n      \"method\": \"Planar lipid bilayer model system, single-molecule fluorescence imaging, Jurkat T cells\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reconstituted model system with single-molecule resolution imaging\",\n      \"pmids\": [\"19398758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD2 and GPI-anchored CD48 cooperate hierarchically in building the early TCR signalosome; CD2 associates with TCR/CD3 upon T cell activation irrespective of CD48 expression and recruits Lck; CD48 then shuttles the transmembrane adaptor LAT to the TCR/CD3 complex in a CD2-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, CD48 knockdown/knockout, LAT and Lck recruitment assays, IL-2 production\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis by sequential co-IP and genetic KD defining hierarchy\",\n      \"pmids\": [\"19494291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD2 localizes to the outer edge of the mature immunological synapse (the 'CD2 corolla') where it captures engaged CD28, ICOS, CD226 and SLAM-F1 co-stimulators; CD2-CD58 interactions in the corolla amplify phosphorylated SFK, LAT and PLC-γ signaling by ~77% versus central CD2-CD58; engaged PD-1 invades the CD2 corolla and buffers CD2-mediated TCR signal amplification; CD2 cytoplasmic tail motifs and copy number control corolla formation.\",\n      \"method\": \"Super-resolution/confocal imaging with cellular and artificial APC, genetic CD2 mutants, phospho-signaling measurements, primary T cell experiments\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal imaging and biochemical methods with defined mutants, >100 citations\",\n      \"pmids\": [\"32929275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD2 on T cells forms cis interactions with its ligand CD48 within the same T cell membrane (demonstrated by FRET); these T cell-intrinsic cis CD2-CD48 interactions are required for robust TCR signaling (protein tyrosine phosphorylation); CD48 is needed on T cells but not APCs for T cell activation (except during cytotoxicity where CD48 on APCs is also required); mass spectrometry of knock-in-tagged CD2 reveals association with TCR complex components and Lck.\",\n      \"method\": \"FRET in nonimmune cells, CD2/CD48 knockout mouse strains, mass spectrometry of CD2-KI tag IP, PTK phosphorylation assays, cytotoxicity assays\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — FRET structural evidence + KO epistasis + MS interactome in single study\",\n      \"pmids\": [\"35930657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CD59 (a GPI-anchored complement regulatory protein) functions as a second ligand for CD2 on T cells; CD2+ transfectants form rosettes with CD59-expressing CHO cells, blocked by anti-CD59 and anti-CD2 mAbs; 125I-CD59 binds specifically to CD2+ CHO cells; CD59 binding induces CD2R epitope expression.\",\n      \"method\": \"Rosette assays with transfected CHO cells, 125I-labeled CD59 binding, antibody blocking\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay with radiolabeled ligand, single lab\",\n      \"pmids\": [\"1385156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD2 and CD3 independently associate with CD5 in T lymphocytes; CD5 is tyrosine phosphorylated after CD3 stimulation but dephosphorylated after CD2 crosslinking; this difference correlates with decreased SHP-1 activity in CD3 pathway versus enhanced SHP-1 after CD2 triggering, defining a regulatory link between CD2 and the phosphatase SHP-1 via CD5.\",\n      \"method\": \"Co-immunoprecipitation in CD3- and CD2-deficient cells, CD5 phosphorylation assays, SHP-1 activity assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP in defined mutant cells with phosphatase activity assay, single lab\",\n      \"pmids\": [\"10510361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Double knockout of CD2 and CD28 in mice causes profound defect in T cell activation by soluble anti-CD3 and antigen but not by immobilized anti-CD3, indicating CD2 and CD28 function coordinately to facilitate T cell-APC interactions for efficient TCR signaling.\",\n      \"method\": \"Double KO mice, T cell activation assays with soluble vs. immobilized stimuli\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double-KO epistasis with defined phenotypic readout\",\n      \"pmids\": [\"10725714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CD2 promotes membrane nanotube formation between NK cells and susceptible target cells; CD2-CD58/48 receptor-ligand interaction is required for nanotube formation; CD2 localizes to nanotube tips; blocking LFA-1-ICAM or 2B4-CD48 interactions does not block nanotube formation, indicating specificity for CD2.\",\n      \"method\": \"YTS NK cell line with stable CD2 expression, anti-CD2/CD58 blocking, live-cell fluorescence microscopy, cytotoxicity assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — stable cell line reconstitution with receptor-specific blocking, single lab\",\n      \"pmids\": [\"23112830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Salt bridges between CD2 and CD58 primarily determine tensile strength of the CD2-CD58 adhesive bond; specific charge mutations (D31A, K41A, K51A, K91A in CD2) reduce equilibrium binding affinity and adhesion strength, confirmed by surface plasmon resonance and surface force apparatus measurements.\",\n      \"method\": \"Site-directed mutagenesis, surface plasmon resonance, surface force apparatus adhesion measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with quantitative biophysical binding and force measurements\",\n      \"pmids\": [\"17172599\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD2 is a T/NK cell surface glycoprotein that functions as an adhesion and co-stimulatory receptor by binding CD58 (humans) or CD48 (rodents) in both trans (on APCs) and cis (on the same T cell) configurations; its low-affinity extracellular Ig domain interaction is amplified by lateral receptor mobility and N-glycosylation-dependent domain stability, while its proline-rich cytoplasmic tail recruits a signaling complex including CD3ζ, p59fyn, p56lck, PLCγ1, and adaptors (CD2BP2, p62dok), enabling CD2 to position itself in the outer 'corolla' of the immunological synapse to boost TCR/SFK/LAT/PLCγ1 signaling, with PD-1 counteracting this amplification, and to promote T cell polarization, nanotube formation, and scanning of APC surfaces.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CD2 is a T and NK cell surface glycoprotein of the immunoglobulin superfamily that functions as a constitutive adhesion receptor and co-stimulatory signal amplifier, lowering the antigen dose threshold for T cell activation. Its N-terminal Ig domain binds CD58 (human) or CD48 (rodent) with low micromolar affinity stabilized by N-glycosylation at Asn65 and salt bridges at the binding interface; lateral receptor mobility on the membrane amplifies this weak interaction into effective cell-cell adhesion [PMID:3313052, PMID:1717480, PMID:1385399, PMID:17172599]. The proline-rich cytoplasmic tail recruits a signaling complex including CD3ζ, p59fyn, p56lck, and adaptor CD2BP2, coupling CD2 to PLC-γ1 phosphorylation, Ca²⁺ mobilization, and MAPK activation—with p59fyn serving as the critical upstream kinase and p62dok acting as a negative regulator—while CD2 also engages in cis interactions with CD48 on the same T cell to support TCR signaling [PMID:1351920, PMID:7912674, PMID:11093170, PMID:9843987, PMID:11254695, PMID:35930657]. At the immunological synapse, CD2 localizes to an outer corolla where it captures co-stimulatory receptors and amplifies SFK/LAT/PLC-γ1 signaling by ~77% compared to centrally positioned CD2–CD58 contacts, a function counteracted by PD-1 invasion of this domain [PMID:32929275, PMID:19398758].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Identifying CD58 (LFA-3) as the counter-receptor for CD2 established the molecular basis of the T cell adhesion pathway and showed that this interaction provides a co-stimulatory signal for T cell activation.\",\n      \"evidence\": \"cDNA cloning and expression of LFA-3, functional adhesion assays, and T cell activation with anti-CD2 mAbs plus natural ligand\",\n      \"pmids\": [\"3313052\", \"3102975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of CD2-CD58 interaction on cell surfaces unknown\", \"Structural basis of binding not yet resolved\", \"Relative contribution versus TCR/CD3 not quantified\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Mapping the LFA-3 binding site to the N-terminal Ig domain of CD2 (Kd ~0.4 µM) and showing independence from the cytoplasmic tail defined CD2 as a modular receptor with separable adhesion and signaling functions.\",\n      \"evidence\": \"Baculovirus-expressed truncated CD2 fragments, circular dichroism, binding assays\",\n      \"pmids\": [\"2576417\", \"2466941\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of CD2 domain 1 not yet determined\", \"Whether post-translational modifications regulate binding affinity unresolved\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Demonstrating that CD2 signaling requires CD3ζ expression established that CD2 does not signal autonomously but is coupled to the TCR/CD3 complex.\",\n      \"evidence\": \"CD3-deficient Jurkat mutants reconstituted by CD3ζ transfection; Ca²⁺, phosphoinositide, and IL-2 readouts\",\n      \"pmids\": [\"2901344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physical nature of CD2–CD3ζ coupling not identified\", \"Whether coupling is direct or via intermediates unknown\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Physical association of CD2 with CD45 phosphatase suggested a mechanism for how CD2 engagement modulates tyrosine phosphorylation cascades at the T cell surface.\",\n      \"evidence\": \"Chemical crosslinking and co-immunoprecipitation in human and mouse T lymphocytes\",\n      \"pmids\": [\"1970422\", \"1980615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of CD45 dissociation from CD2 not tested genetically\", \"Whether CD45 dephosphorylates CD2-associated kinases directly unclear\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Showing that CD2 adhesion is constitutively active while LFA-1 requires TCR activation positioned CD2 as the initiator of T cell–APC contact, and demonstrating that lateral membrane mobility of both CD2 and GPI-anchored LFA-3 amplifies adhesion explained how a low-affinity interaction achieves functional binding.\",\n      \"evidence\": \"Cell adhesion assays across activation states; reconstituted planar lipid bilayers with FRAP and laminar flow\",\n      \"pmids\": [\"1672642\", \"1717480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of GPI vs. transmembrane LFA-3 isoforms not established\", \"Role of cytoskeletal anchoring of CD2 in mobility regulation not defined\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Multiple concurrent discoveries refined CD2 structure-function: CD3ζ cytoplasmic domain was shown to be necessary and sufficient for CD2 signal coupling; TCR crosslinking was found to upregulate CD2 avidity via its cytoplasmic C-terminus; and N-glycosylation at Asn65 was established as essential for domain 1 stability and ligand binding.\",\n      \"evidence\": \"CD8α/CD3ζ chimera reconstitution in CD3-deficient Jurkat; CD2 cytoplasmic tail mutagenesis with CD58 binding assays; Asn65Gln mutagenesis with mass spectrometry\",\n      \"pmids\": [\"1351920\", \"1353888\", \"1385399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism of avidity regulation unknown\", \"Whether glycosylation directly contacts LFA-3 or acts indirectly via folding not resolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of CD48 as the rodent CD2 ligand with low-affinity direct binding via domain 1 extended the CD2 adhesion paradigm to rodent models used in subsequent knockout studies.\",\n      \"evidence\": \"Soluble CD48-CD4 chimera binding, sucrose gradient ultracentrifugation, bacterially expressed CD2 domain 1\",\n      \"pmids\": [\"8099016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD48 and CD58 use identical binding surfaces on CD2 not confirmed\", \"Glycosylation independence for CD48 binding contrasts with CD58 requirement—mechanistic basis unclear\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of a physical CD2–CD3ζ–p59fyn–p56lck signaling complex provided the first molecular framework for how CD2 engagement activates Src-family kinases.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro kinase assays, double immunofluorescence capping in T cells\",\n      \"pmids\": [\"7912674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect association among complex members not resolved\", \"Relative kinase contributions not yet determined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Discovery of CD2BP2 binding to proline-rich PPPGHR motifs via a GYF domain revealed a cytoplasmic adaptor mechanism for CD2-specific signal enhancement, while demonstration of lck-independent JNK/AP-1 activation defined an alternative CD2 signaling branch.\",\n      \"evidence\": \"Yeast two-hybrid, NMR of GYF domain, IL-2 reporter in Jurkat; JNK assays in lck-deficient Jurkat lines\",\n      \"pmids\": [\"9843987\", \"9727049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of CD2BP2 in primary T cells not tested\", \"Upstream activator of JNK in CD2 pathway unidentified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"CD2 knockout mice revealed that CD2 sets a quantitative antigen sensitivity threshold: CD2-deficient T cells require 3–10-fold more antigen for equivalent activation, establishing CD2's non-redundant costimulatory role in vivo.\",\n      \"evidence\": \"CD2 KO × TCR-transgenic mice, dose-response proliferation, conjugate formation, Ca²⁺ flux\",\n      \"pmids\": [\"10562314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo infection or autoimmune phenotypes of CD2 KO not characterized\", \"Compensation by LFA-1 pathway quantified only additively in vitro\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Genetic studies using fyn−/− mice and CD2/CD28 double knockouts established p59fyn as the critical upstream kinase for CD2 (regulating PLC-γ1, Vav, PKC-θ, Dok, FAK, Pyk2) and showed CD2 and CD28 coordinately facilitate T cell–APC interaction.\",\n      \"evidence\": \"fyn−/− mice with hCD2 transgene; CD2/CD28 double KO mice; Ca²⁺, MAPK, substrate phosphorylation assays\",\n      \"pmids\": [\"11093170\", \"10725714\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether fyn is required cell-autonomously for CD2 signaling in all T cell subsets unknown\", \"Redundancy between CD2 and CD28 at the molecular signaling level not dissected\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"CD2 was shown to be inducibly recruited to lipid rafts upon engagement (requiring ectodomain conformational change), while p62dok was identified as a CD2-specific negative regulator that inhibits PLC-γ1 and ERK1/2 downstream of CD2 but not CD3.\",\n      \"evidence\": \"Lipid raft fractionation with cholesterol depletion and CD2 mutants; p62dok overexpression in Jurkat with Ca²⁺, PLC-γ1, ERK readouts\",\n      \"pmids\": [\"11376005\", \"11254695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Raft recruitment kinetics in primary T cells not measured\", \"Physiological relevance of p62dok regulation of CD2 not tested in vivo\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Live-cell imaging revealed that CD2–CD58 engagement induces T cell polarization, uropod enrichment of CD2 (~100-fold), and scanning motility along APCs, establishing CD2 as a driver of T cell morphological dynamics during APC surveillance.\",\n      \"evidence\": \"Time-lapse DIC and immunofluorescence on living T cells, MLCK and integrin inhibition\",\n      \"pmids\": [\"12032326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether scanning motility depends on CD2 signaling vs. adhesion alone not separated\", \"In vivo relevance of uropod CD2 enrichment unconfirmed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Biophysical dissection of CD2–CD58 bonds identified salt bridges as the primary determinants of tensile strength, and CD2 was found to promote membrane nanotube formation between NK cells and targets.\",\n      \"evidence\": \"Surface plasmon resonance and surface force apparatus with charge-reversal mutants; live-cell fluorescence of YTS NK cells with anti-CD2/CD58 blocking\",\n      \"pmids\": [\"17172599\", \"23112830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nanotube finding from a single NK cell line with overexpressed CD2\", \"Whether nanotube formation is relevant to T cells not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Single-cell imaging showed CD2–CD58 interaction at the immunological synapse sustains antigen-induced Ca²⁺ signals and is required for PLC-γ1 recruitment and Tyr783 phosphorylation at the IS, establishing the biochemical convergence point of TCR and CD2 signaling.\",\n      \"evidence\": \"Single-cell Ca²⁺ imaging, IS immunofluorescence, PLC-γ1 phospho-assays, anti-CD58 blocking\",\n      \"pmids\": [\"17220479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PLC-γ1 recruitment is via direct CD2 interaction or via LAT scaffolding not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Nanoscale elongation of the CD2–CD48 intermembrane distance by 2–4 nm reduced adhesion 10-fold and reorganized the IS, revealing that precise intermembrane spacing is a critical biophysical parameter for CD2 function.\",\n      \"evidence\": \"Electron tomography, CD48 Ig-domain extension chimeras, primary T cell activation assays\",\n      \"pmids\": [\"18826951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether spacing effects apply identically to CD2–CD58 in human system not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Reconstituted bilayer and co-IP studies demonstrated that CD2 engagement alone nucleates TCR-ζ/Lck/LAT microclusters before TCR triggering, and that CD48 hierarchically shuttles LAT to the TCR/CD3 complex in a CD2-dependent manner.\",\n      \"evidence\": \"Single-molecule fluorescence on planar bilayers (Jurkat); co-IP with CD48 knockdown, LAT/Lck recruitment assays\",\n      \"pmids\": [\"19398758\", \"19494291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether pre-formed CD2 microclusters are present in primary T cells in vivo unknown\", \"Molecular basis of CD2-dependent LAT shuttling by CD48 not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Super-resolution imaging defined the 'CD2 corolla' at the outer immunological synapse where CD2–CD58 amplifies SFK/LAT/PLC-γ signaling by ~77% over central contacts; PD-1 invades this corolla to buffer signal amplification, providing a spatial mechanism for checkpoint inhibition of CD2-augmented TCR signaling.\",\n      \"evidence\": \"Super-resolution and confocal imaging with cellular and artificial APCs, genetic CD2 mutants, phospho-signaling measurements in primary T cells\",\n      \"pmids\": [\"32929275\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether corolla disruption fully accounts for PD-1 inhibitory function unknown\", \"Contribution of individual cytoplasmic tail motifs to corolla architecture incompletely mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"FRET-based detection of cis CD2–CD48 interactions on the same T cell, combined with knockout epistasis showing T cell-intrinsic CD48 is required for TCR signaling, overturned the purely trans-interaction model and revealed that CD2 functions through both cis and trans ligand engagement.\",\n      \"evidence\": \"FRET in nonimmune cells, CD2/CD48 KO mice, CD2 knock-in tag mass spectrometry, PTK and cytotoxicity assays\",\n      \"pmids\": [\"35930657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of cis vs. trans binding not determined\", \"Whether cis interaction occurs with CD58 in human T cells not addressed\", \"Relative signaling contribution of cis vs. trans engagement not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of CD2 corolla formation, the atomic mechanism by which cis CD2–ligand interactions promote TCR signaling, and how CD2 integrates with checkpoint receptors beyond PD-1 remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of CD2 in a cis complex\", \"Mechanism of PD-1 invasion into the CD2 corolla not defined at molecular level\", \"Role of CD2 in non-conventional T cell subsets (γδ, NKT) mechanistically uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 6, 29]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [12, 22, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 5, 16, 18, 23, 24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 3, 14, 23, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 11, 15, 19, 23]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 6, 18, 20]}\n    ],\n    \"complexes\": [\n      \"TCR/CD3 signaling complex\"\n    ],\n    \"partners\": [\n      \"CD58\",\n      \"CD48\",\n      \"CD247\",\n      \"FYN\",\n      \"LCK\",\n      \"CD2BP2\",\n      \"PTPRC\",\n      \"DOK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}